Macrocycle versus podant-type neutral ionophore in potentiometric detection of mucolytic agents following separation by various HPLC modes

被引:8
作者
Bazylak, G
Nagels, LJ
Monge, ME
机构
[1] Ludwik Rydygier Med Univ, Fac Pharm, Dept Drug Chem, PL-85067 Bydgoszcz, Poland
[2] Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE, Buenos Aires, DF, Argentina
[3] Univ Antwerp, RUCA, Fac Sci & Biomed, Dept Chem, B-2020 Antwerp, Belgium
关键词
column liquid chromatography; potentiometric detection; lipophilic drugs; pharmaceutical formulations;
D O I
10.1007/BF02491762
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Potentiometric detection of lipophilic drugs such as clenbuterol, ambroxol and bromhexine in standard-bore cyano and narrow-bore hybrid, reversed-phase HPLC systems was developed to enable specific determination of these mucolytic agents in some marketed oral-formulations. The macrocycle and podant-type, neutral ionophores, respectively: hexakis(2,3,6-tri-O-octyl)-alpha-cycloclextrin (CDX) and NNN',N'-tetracyclohexyl-oxybis(o-phenyleneoxy)diacetamide (TOPA), were used to construct PVC-based, liquid membrane electrodes. In acidic aqueous-acetonitrile, mobile phases both ionophores improved the sensitivity of these electrodes for mucolytic agents when compared to single-wavelength UV detection - as well as with the ionophore-free based electrode. in the case of bromhexine, indicating highest lipophilicity (IogP 6.40), detection limits of 2.6 x 10(-10) and 1.4 x 10(-10) M (injected concentration) were achieved with a signal-to-noise (SIN) ratio of 3 with the TORA-modified, liquid membrane electrode in the various RP-HPLC systems. The results of procedures validated for simultaneous potentiometric determination of clenbuterol and ambroxol in tablets marketed in different countries are also presented.
引用
收藏
页码:757 / 765
页数:9
相关论文
共 58 条
[1]  
[Anonymous], SENS ACTUATORS B
[2]  
Argekar AP, 1998, JPC-J PLANAR CHROMAT, V11, P254
[3]   Integrated acquisition of analytical and biopharmaceutical screening data for beta-adrenergic-drugs employing diversified macrocycle supported potentiometric detection in HPLC systems [J].
Bazylak, G ;
Nagels, LJ .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (16) :1547-1566
[4]  
Bazylak G, 1999, CHIRALITY, V11, P387, DOI 10.1002/(SICI)1520-636X(1999)11:5/6<387::AID-CHIR7>3.0.CO
[5]  
2-U
[6]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF AMBROXOL IN PHARMACEUTICALS [J].
BRIZZI, V ;
PASETTI, U .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (01) :107-109
[7]  
Chlubek D, 2001, Ginekol Pol, V72, P804
[8]   DETERMINATION OF AMBROXOL IN BIOLOGICAL-MATERIAL BY GAS-CHROMATOGRAPHY WITH ELECTRON-CAPTURE DETECTION [J].
COLOMBO, L ;
MARCUCCI, F ;
MARINI, MG ;
PIERFEDERICI, P ;
MUSSINI, E .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 530 (01) :141-147
[9]  
COUET W, 1989, INT J CLIN PHARM TH, V27, P467
[10]   Clenbuterol plasma pharmacokinetics in cattle [J].
Dave, M ;
Sauer, MJ ;
Fallon, RJ .
ANALYST, 1998, 123 (12) :2697-2699